US Stock MarketDetailed Quotes

ARQT Arcutis Biotherapeutics

Watchlist

8.835
+0.515+6.19%

Trading May 1 15:58 ET

1.02BMarket Cap-2337P/E (TTM)

Arcutis Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

4.14%-247.06M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.49M

-41.02%-80.34M

-47.58%-257.72M

-37.43%-71.07M

-65.58%-67.7M

-72.98%-61.98M

-23.31%-56.98M

Net income from continuing operations

15.83%-262.14M

7.96%-66.28M

58.44%-44.77M

-5.32%-70.99M

-24.53%-80.1M

-50.93%-311.46M

-0.97%-72.02M

-89.03%-107.71M

-60.46%-67.41M

-78.47%-64.32M

Operating gains losses

--849K

----

Depreciation and amortization

62.85%1.52M

10.95%385K

37.23%387K

149.03%386K

142.00%363K

105.73%934K

155.15%347K

143.10%282K

49.04%155K

53.06%150K

Other non cash items

-86.52%4.39M

1.09%1.11M

-96.37%1.11M

129.89%1.09M

129.51%1.08M

10,435.60%32.56M

1,364.00%1.1M

40,046.05%30.51M

508.97%475K

488.75%471K

Change In working capital

-130.97%-23.5M

105.54%411K

-844.53%-9.18M

-60.30%-5.73M

-2,029.08%-9.01M

-381.08%-10.18M

-157.76%-7.41M

-86.86%1.23M

-517.29%-3.57M

97.83%-423K

-Change in receivables

-105.12%-17.35M

-6.02%-6.39M

9.09%-2.21M

---4.44M

---4.31M

---8.46M

---6.03M

---2.43M

--0

-Change in inventory

25.21%-5.62M

124.29%779K

20.15%-3.44M

---1.92M

---1.04M

---7.51M

---3.21M

---4.31M

--0

-Change in prepaid assets

-348.30%-8.62M

24.98%1.47M

-3,680.42%-8.59M

-55.27%921K

---2.42M

147.37%3.47M

196.62%1.17M

-93.50%240K

-27.96%2.06M

--0

-Change in payables and accrued expense

217.11%8.75M

491.98%4.72M

-33.32%5.23M

97.80%-122K

-222.32%-1.08M

-74.24%2.76M

-94.33%798K

39.86%7.84M

-165.22%-5.54M

95.12%-336K

-Change in other current liabilities

-51.73%-657K

-12.00%-168K

-52.78%-165K

-86.36%-164K

-83.91%-160K

-278.19%-433K

-552.17%-150K

-217.39%-108K

-200.00%-88K

-201.16%-87K

Cash from discontinued investing activities

Operating cash flow

4.14%-247.06M

20.86%-56.24M

35.03%-43.98M

-7.27%-66.49M

-41.02%-80.34M

-47.58%-257.72M

-37.43%-71.07M

-65.58%-67.7M

-72.98%-61.98M

-23.31%-56.98M

Investing cash flow

Cash flow from continuing investing activities

306.69%180.23M

-247.36%-62.19M

123.09%45.55M

69.54%89.12M

604.39%107.75M

-14.81%-87.2M

79.59%42.2M

-5,783.15%-197.26M

131.87%52.57M

-75.33%15.3M

Net PPE purchase and sale

-28.53%-428K

95.12%-6K

-966.67%-64K

-245.00%-276K

33.87%-82K

66.53%-333K

52.87%-123K

95.62%-6K

-86.05%-80K

77.62%-124K

Net intangibles purchase and sale

--0

----

---22.95M

--0

----

Net investment purchase and sale

382.65%180.66M

-246.91%-62.18M

126.17%45.61M

69.81%89.39M

599.26%107.83M

14.73%-63.92M

78.13%42.32M

-4,931.10%-174.31M

131.93%52.65M

-75.35%15.42M

Cash from discontinued investing activities

Investing cash flow

306.69%180.23M

-247.36%-62.19M

123.09%45.55M

69.54%89.12M

604.39%107.75M

-14.81%-87.2M

79.59%42.2M

-5,783.15%-197.26M

131.87%52.57M

-75.33%15.3M

Financing cash flow

Cash flow from continuing financing activities

-66.43%101.32M

10,221.10%99.29M

-99.70%867K

-5.66%1.07M

-99.32%100K

7.04%301.8M

-98.68%962K

452,263.49%284.99M

-4.80%1.13M

-92.92%14.72M

Net issuance payments of debt

--0

----

68.95%125M

--0

----

Net common stock issuance

-43.82%98.9M

--98.9M

--0

-15.15%176.05M

--0

--161.59M

--0

-93.03%14.46M

Proceeds from stock option exercised by employees

-17.56%2.42M

-59.67%388K

48.46%867K

-5.66%1.07M

-61.69%100K

39.44%2.94M

81.17%962K

826.98%584K

-4.80%1.13M

-19.69%261K

Net other financing activities

----

-33.60%-2.19M

--0

----

Cash from discontinued financing activities

Financing cash flow

-66.43%101.32M

10,221.10%99.29M

-99.70%867K

-5.66%1.07M

-99.32%100K

7.04%301.8M

-98.68%962K

452,263.49%284.99M

-4.80%1.13M

-92.92%14.72M

Net cash flow

Beginning cash position

-44.00%54.88M

30.95%108.4M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

47.08%97.99M

55.25%82.78M

-30.80%62.75M

-75.53%71.03M

47.08%97.99M

Current changes in cash

180.01%34.5M

31.40%-19.14M

-87.86%2.43M

386.09%23.7M

202.02%27.51M

-237.46%-43.12M

-162.46%-27.9M

153.63%20.03M

95.85%-8.28M

-112.06%-26.96M

Effect of exchange rate changes

---50K

--68K

---75K

--9K

---52K

--0

End cash Position

62.78%89.32M

30.95%108.4M

69.00%106.04M

15.91%82.33M

-44.00%54.88M

55.25%82.78M

-30.80%62.75M

-75.53%71.03M

Free cash flow

11.93%-247.49M

20.98%-56.25M

51.41%-44.05M

-7.57%-66.76M

-40.85%-80.43M

-60.00%-281M

-36.98%-71.19M

-120.99%-90.65M

-72.99%-62.06M

-22.12%-57.1M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	4.14%-247.06M	20.86%-56.24M	35.03%-43.98M	-7.27%-66.49M	-41.02%-80.34M	-47.58%-257.72M	-37.43%-71.07M	-65.58%-67.7M	-72.98%-61.98M	-23.31%-56.98M
Net income from continuing operations	15.83%-262.14M	7.96%-66.28M	58.44%-44.77M	-5.32%-70.99M	-24.53%-80.1M	-50.93%-311.46M	-0.97%-72.02M	-89.03%-107.71M	-60.46%-67.41M	-78.47%-64.32M
Operating gains losses	--849K	----	----	----	----	----	----	----	----	----
Depreciation and amortization	62.85%1.52M	10.95%385K	37.23%387K	149.03%386K	142.00%363K	105.73%934K	155.15%347K	143.10%282K	49.04%155K	53.06%150K
Other non cash items	-86.52%4.39M	1.09%1.11M	-96.37%1.11M	129.89%1.09M	129.51%1.08M	10,435.60%32.56M	1,364.00%1.1M	40,046.05%30.51M	508.97%475K	488.75%471K
Change In working capital	-130.97%-23.5M	105.54%411K	-844.53%-9.18M	-60.30%-5.73M	-2,029.08%-9.01M	-381.08%-10.18M	-157.76%-7.41M	-86.86%1.23M	-517.29%-3.57M	97.83%-423K
-Change in receivables	-105.12%-17.35M	-6.02%-6.39M	9.09%-2.21M	---4.44M	---4.31M	---8.46M	---6.03M	---2.43M	--0	--0
-Change in inventory	25.21%-5.62M	124.29%779K	20.15%-3.44M	---1.92M	---1.04M	---7.51M	---3.21M	---4.31M	--0	--0
-Change in prepaid assets	-348.30%-8.62M	24.98%1.47M	-3,680.42%-8.59M	-55.27%921K	---2.42M	147.37%3.47M	196.62%1.17M	-93.50%240K	-27.96%2.06M	--0
-Change in payables and accrued expense	217.11%8.75M	491.98%4.72M	-33.32%5.23M	97.80%-122K	-222.32%-1.08M	-74.24%2.76M	-94.33%798K	39.86%7.84M	-165.22%-5.54M	95.12%-336K
-Change in other current liabilities	-51.73%-657K	-12.00%-168K	-52.78%-165K	-86.36%-164K	-83.91%-160K	-278.19%-433K	-552.17%-150K	-217.39%-108K	-200.00%-88K	-201.16%-87K
Cash from discontinued investing activities
Operating cash flow	4.14%-247.06M	20.86%-56.24M	35.03%-43.98M	-7.27%-66.49M	-41.02%-80.34M	-47.58%-257.72M	-37.43%-71.07M	-65.58%-67.7M	-72.98%-61.98M	-23.31%-56.98M
Investing cash flow
Cash flow from continuing investing activities	306.69%180.23M	-247.36%-62.19M	123.09%45.55M	69.54%89.12M	604.39%107.75M	-14.81%-87.2M	79.59%42.2M	-5,783.15%-197.26M	131.87%52.57M	-75.33%15.3M
Net PPE purchase and sale	-28.53%-428K	95.12%-6K	-966.67%-64K	-245.00%-276K	33.87%-82K	66.53%-333K	52.87%-123K	95.62%-6K	-86.05%-80K	77.62%-124K
Net intangibles purchase and sale	--0	--0	----	----	----	---22.95M	--0	----	----	----
Net investment purchase and sale	382.65%180.66M	-246.91%-62.18M	126.17%45.61M	69.81%89.39M	599.26%107.83M	14.73%-63.92M	78.13%42.32M	-4,931.10%-174.31M	131.93%52.65M	-75.35%15.42M
Cash from discontinued investing activities
Investing cash flow	306.69%180.23M	-247.36%-62.19M	123.09%45.55M	69.54%89.12M	604.39%107.75M	-14.81%-87.2M	79.59%42.2M	-5,783.15%-197.26M	131.87%52.57M	-75.33%15.3M
Financing cash flow
Cash flow from continuing financing activities	-66.43%101.32M	10,221.10%99.29M	-99.70%867K	-5.66%1.07M	-99.32%100K	7.04%301.8M	-98.68%962K	452,263.49%284.99M	-4.80%1.13M	-92.92%14.72M
Net issuance payments of debt	--0	--0	----	----	----	68.95%125M	--0	----	----	----
Net common stock issuance	-43.82%98.9M	--98.9M	--0	--0	--0	-15.15%176.05M	--0	--161.59M	--0	-93.03%14.46M
Proceeds from stock option exercised by employees	-17.56%2.42M	-59.67%388K	48.46%867K	-5.66%1.07M	-61.69%100K	39.44%2.94M	81.17%962K	826.98%584K	-4.80%1.13M	-19.69%261K
Net other financing activities	----	----	----	----	----	-33.60%-2.19M	--0	----	----	----
Cash from discontinued financing activities
Financing cash flow	-66.43%101.32M	10,221.10%99.29M	-99.70%867K	-5.66%1.07M	-99.32%100K	7.04%301.8M	-98.68%962K	452,263.49%284.99M	-4.80%1.13M	-92.92%14.72M
Net cash flow
Beginning cash position	-44.00%54.88M	30.95%108.4M	69.00%106.04M	15.91%82.33M	-44.00%54.88M	47.08%97.99M	55.25%82.78M	-30.80%62.75M	-75.53%71.03M	47.08%97.99M
Current changes in cash	180.01%34.5M	31.40%-19.14M	-87.86%2.43M	386.09%23.7M	202.02%27.51M	-237.46%-43.12M	-162.46%-27.9M	153.63%20.03M	95.85%-8.28M	-112.06%-26.96M
Effect of exchange rate changes	---50K	--68K	---75K	--9K	---52K	--0	--0	--0	--0	--0
End cash Position	62.78%89.32M	62.78%89.32M	30.95%108.4M	69.00%106.04M	15.91%82.33M	-44.00%54.88M	-44.00%54.88M	55.25%82.78M	-30.80%62.75M	-75.53%71.03M
Free cash flow	11.93%-247.49M	20.98%-56.25M	51.41%-44.05M	-7.57%-66.76M	-40.85%-80.43M	-60.00%-281M	-36.98%-71.19M	-120.99%-90.65M	-72.99%-62.06M	-22.12%-57.1M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall